Proton pump inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Proton pump inhibitors act by irreversible inhibition of the H+/K+ ATPase, in the parietal cells of the stomach. It markedly inhibits gastric acid secretion and has a long duration of action. They are used for treatment of gastric and duodenal ulcers, gastroesophageal reflux disease and other excessive gastrointestinal acid secretory disorders.
| Drug Name |
Reviews | Avg. Ratings |
|
|---|---|---|---|
| omeprazole/ sodium bicarbonate systemic (Pro, More...) |
15 Review(s) |
Rate It! | 9.0 |
| esomeprazole systemic (Pro, More...) |
50 Review(s) |
Rate It! | 8.9 |
| rabeprazole systemic (Pro, More...) |
29 Review(s) |
Rate It! | 8.8 |
| pantoprazole systemic (Pro, More...) |
35 Review(s) |
Rate It! | 8.7 |
| lansoprazole systemic (Pro, More...) |
27 Review(s) |
Rate It! | 8.4 |
| dexlansoprazole systemic (Pro, More...) |
58 Review(s) |
Rate It! | 8.1 |
| omeprazole systemic (Pro, More...) |
46 Review(s) |
Rate It! | 8.0 |
See also
Medical conditions associated with proton pump inhibitors:
- Aspiration Pneumonia
- Barrett's Esophagus
- Duodenal Ulcer
- Duodenal Ulcer Prophylaxis
- Erosive Esophagitis
- Gastrointestinal Hemorrhage
- GERD
- Helicobacter Pylori Infection
- Indigestion
- Multiple Endocrine Adenomas
- NSAID-Induced Gastric Ulcer
- NSAID-Induced Ulcer Prophylaxis
- Pathological Hypersecretory Conditions
- Peptic Ulcer
- Stomach Ulcer
- Stress Ulcer Prophylaxis
- Systemic Mastocytosis
- Zollinger-Ellison Syndrome

